NCT03019991 - Safety, Tolerability and Pharmacokinetics of Danoprevir/r in Healthy Volunteers China | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Healthy

Interventions

DRUG

Danoprevir

Danoprevir(DNV)administered orally 100mg QD on day 1, day 4 and day 14; 100mg BID on day 5 -day 13

DRUG

Ritonavir

Ritonavir administered orally 100mg QD on day 4 and day 14; 100mg BID on day 5 -day 13

DRUG

Placebo

ASC 08 Placebo administered orally 100mg QD on day 1, day 4 and day 14; 100mg BID on day 5 -day 13